The FDA issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drugs that have questionable sterility and the potential to harm users.
The FDA issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drugs that have questionable sterility and the potential to harm users.